Developer docs
API playgroundTry for free, no card

Search company profiles

Aphria

Full company profile

uuid000439m

Namestring
Aphria
Legal namestring
Aphria
Websiteurl
aphria.ca
Company typeenum
Private
Founded yearint
2014
Short descriptiontext

Aphria is a Canadian medical cannabis brand operating as a sub-brand of Tilray Medical within Tilray Brands, Inc. It sells dried flower, oils, capsules, and edibles to registered Canadian patients via a Shopify-based direct-to-consumer e-commerce platform alongside four sister brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLeamington, Canada
HQ citystring
Leamington
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis products, cannabis flower products, cannabis oil capsules, cannabis edible products, medical cannabis brands
Industry3 codes
1Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.)
CodeCRANAFAJPrimaryYes
2Cannabis Online Ordering for Delivery (Marketplace/Aggregator)
CodeCRANAGADPrimaryNo
3Vape & Cartridge Accessories (Batteries, Chargers, Pods)
CodeCRANAHAHPrimaryNo
NAICS code2 codes
  • Health and Personal Care Retailers456
  • Pharmacies and Drug Retailers456110
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Medical Cannabis
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Cannabis Product Sales
TypeOne Time License
Description

Direct-to-consumer sales of medical cannabis products including flower, oils, capsules, pre-rolls, edibles, and beverages through the tilraymedical.ca e-commerce platform. Unit-based pricing per product with no subscription requirements.

tilraymedical.ca
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Pricing details1 tier
1Individual product purchases at unit prices
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products priced per unit: Pearls Blue Razzleberry 3:1 Gummies ($6.49), Portal Redshift Berry Lemonade Liquid Diamond 510 Cartridge ($45.00), Pineapple Marker #148 - Broken Coast 5g ($50.00), Amnesia OG 10g ($80.00), No Future - The Orange One Gummy ($5.49). Special pricing programs available for Veterans through Warrior Wellness Program. Insurance coverage and direct billing options available.

tilraymedical.ca
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Aphria is a medical cannabis sub-brand sold through Tilray Medical's direct-to-consumer e-commerce platform (tilraymedical.ca) in Canada. The brand offers cannabis products including dried flower, oils, capsules, and edibles to registered patients who have submitted a medical document from a healthcare provider. Patients shop and order online with unit-priced products shipped directly across all Canadian provinces and territories.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Tilray Medical operates as a unified medical cannabis e-commerce platform that aggregates five distinct sub-brands—Tilray, Aphria, Symbios, Broken Coast, and Redecan—under a single patient-facing portal. The platform offers a comprehensive product portfolio spanning multiple consumption formats including dried flower, oils, capsules, pre-rolls, infused pre-rolls, edibles, beverages, and cartridge vapes. Patients register through a three-step process requiring healthcare provider documentation, then gain access to brand-specific products with pricing programs including Veterans support and insurance billing integration. The platform serves both direct-to-patient e-commerce and healthcare provider referral channels.

Product and service8 records
1Aphria medical cannabis brand
CategoryMedical Cannabis Brand
Description

Aphria medical cannabis sub-brand offering dried flower, oils, capsules, and edibles to registered Canadian patients through the Tilray Medical platform.

2Pearls Blue Razzleberry 3:1 Gummies
CategoryEdibles
Description

Edible cannabis product with a 3:1 CBD to THC ratio, Blue Razzleberry flavor, priced at $6.49.

3Portal Redshift Berry Lemonade Liquid Diamond 510 Cartridge
CategoryVape Cartridges
Description

Sativa-dominant vape cartridge with liquid diamond concentrate, Berry Lemonade flavor, 0.95g size, priced at $45.00.

4Pineapple Marker #148 - Broken Coast
CategoryFlower
Description

Sativa-dominant dried cannabis flower from Broken Coast brand, 5g package, priced at $50.00.

5Pineapple Marker #151 - Broken Coast
CategoryFlower
Description

Dried cannabis flower from Broken Coast brand, 5g package, priced at $50.00.

6Amnesia OG
CategoryFlower
Description

Dried cannabis flower, 10g package, priced at $80.00.

7No Future - The Orange One Gummy
CategoryEdibles
Description

Cannabis edible gummy product, priced at $5.49.

8Warrior Wellness Program
CategoryPatient Program
Description

Dedicated pricing program providing accessible medical cannabis for Veterans and service members through the Tilray Medical platform.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeEmerging player
Description

Canadian licensed producer with the Qwest brand offering dried flower and pre-rolls. Smaller LP competing in the Canadian cannabis market with similar product formats to Tilray Medical's portfolio.

TypeDirect peer
Description

Major Canadian licensed producer operating multiple brands (Aurora, MedReleaf, CanniMed) and a medical cannabis platform serving patients across Canada. Comparable to Tilray Medical as a scaled Canadian LP with multi-brand DTC medical sales.

TypeDirect peer
Description

Canadian licensed producer with brands including Spinach and PEACE NATURALS. Operates a medical cannabis channel and offers multiple product formats, comparable to Tilray Medical's multi-brand portfolio approach.

TypeDirect peer
Description

One of Canada's largest licensed cannabis producers, with a multi-brand portfolio (Tweed, Spectrum, DOJA) and DTC medical cannabis platform (Spectrum Therapeutics). Directly comparable as a multi-brand Canadian cannabis operator with both medical and consumer offerings.

TypeRegional player
Description

Canadian cannabis retail operator with Canna Cabana stores, plus ecommerce and accessories. Competes in Canadian cannabis retail though more focused on adult-use channels; provides a comparable Canadian-focused cannabis retail model.

TypeDirect peer
Description

Canadian medical cannabis producer offering dried flower, oils, and capsules directly to patients via online platform. Direct competitor to Tilray Medical as a Canadian LP focused on medical patients.

TypeBroad incumbent
Description

Canada's largest pharmacy retailer, which has licensed medical cannabis dispensaries in select provinces. Serves as a broader incumbent entering the medical cannabis space through traditional pharmacy infrastructure.

TypeDirect peer
Description

Canadian licensed cannabis producer with both medical and adult-use brands. Operates a patient registration platform similar to Tilray Medical for medical cannabis distribution across Canada.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aphria

Medical Cannabisaphria.ca

Aphria is a Canadian medical cannabis brand operating as a sub-brand of Tilray Medical within Tilray Brands, Inc. It sells dried flower, oils, capsules, and edibles to registered Canadian patients via a Shopify-based direct-to-consumer e-commerce platform alongside four sister brands.

Aphria firmographics

Firmographics
Name
Aphria
Legal name
Aphria
Website
https://aphria.ca
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
251–500 employees
Short description
Aphria is a Canadian medical cannabis brand operating as a sub-brand of Tilray Medical within Tilray Brands, Inc. It sells dried flower, oils, capsules, and edibles to registered Canadian patients via a Shopify-based direct-to-consumer e-commerce platform alongside four sister brands.
Ownership category
akta.pro rank

Aphria industry classification

Industry
Product category
Medical Cannabis
NAICS
Health and Personal Care Retailers (456), Pharmacies and Drug Retailers (456110)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry
Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ)
akta.pro secondary industries
Cannabis Online Ordering for Delivery (Marketplace/Aggregator) (CRANAGAD), Vape & Cartridge Accessories (Batteries, Chargers, Pods) (CRANAHAH)

Keywords

  • Medical cannabis products
  • Cannabis flower products
  • Cannabis oil capsules
  • Cannabis edible products
  • Medical cannabis brands

Where Aphria is headquartered

Location

Headquarters

HQ city
Leamington
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Aphria business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Cannabis Product Sales: Direct-to-consumer sales of medical cannabis products including flower, oils, capsules, pre-rolls, edibles, and beverages through the tilraymedical.ca e-commerce platform. Unit-based pricing per product with no subscription requirements.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual product purchases at unit prices

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Aphria product offering

Product offering

Core offering

Aphria is a medical cannabis sub-brand sold through Tilray Medical's direct-to-consumer e-commerce platform (tilraymedical.ca) in Canada. The brand offers cannabis products including dried flower, oils, capsules, and edibles to registered patients who have submitted a medical document from a healthcare provider. Patients shop and order online with unit-priced products shipped directly across all Canadian provinces and territories.

Product overview

Tilray Medical operates as a unified medical cannabis e-commerce platform that aggregates five distinct sub-brands—Tilray, Aphria, Symbios, Broken Coast, and Redecan—under a single patient-facing portal. The platform offers a comprehensive product portfolio spanning multiple consumption formats including dried flower, oils, capsules, pre-rolls, infused pre-rolls, edibles, beverages, and cartridge vapes. Patients register through a three-step process requiring healthcare provider documentation, then gain access to brand-specific products with pricing programs including Veterans support and insurance billing integration. The platform serves both direct-to-patient e-commerce and healthcare provider referral channels.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aphria medical cannabis brand Aphria medical cannabis sub-brand offering dried flower, oils, capsules, and edibles to registered Canadian patients through the Tilray Medical platform.
  • Pearls Blue Razzleberry 3:1 Gummies Edible cannabis product with a 3:1 CBD to THC ratio, Blue Razzleberry flavor, priced at $6.49.
  • Portal Redshift Berry Lemonade Liquid Diamond 510 Cartridge Sativa-dominant vape cartridge with liquid diamond concentrate, Berry Lemonade flavor, 0.95g size, priced at $45.00.
  • Pineapple Marker #148 - Broken Coast Sativa-dominant dried cannabis flower from Broken Coast brand, 5g package, priced at $50.00.
  • Pineapple Marker #151 - Broken Coast Dried cannabis flower from Broken Coast brand, 5g package, priced at $50.00.
  • Amnesia OG Dried cannabis flower, 10g package, priced at $80.00.
  • No Future - The Orange One Gummy Cannabis edible gummy product, priced at $5.49.
  • Warrior Wellness Program Dedicated pricing program providing accessible medical cannabis for Veterans and service members through the Tilray Medical platform.

Companies that use Aphria

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Aphria technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Aphria partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Aphria competitors and assessment

Company assessment

Emerging players

  • Decibel Cannabis Company: Canadian licensed producer with the Qwest brand offering dried flower and pre-rolls. Smaller LP competing in the Canadian cannabis market with similar product formats to Tilray Medical's portfolio.

Direct peers

  • Aurora Cannabis Inc. Major Canadian licensed producer operating multiple brands (Aurora, MedReleaf, CanniMed) and a medical cannabis platform serving patients across Canada. Comparable to Tilray Medical as a scaled Canadian LP with multi-brand DTC medical sales.
  • Cronos Group Inc. Canadian licensed producer with brands including Spinach and PEACE NATURALS. Operates a medical cannabis channel and offers multiple product formats, comparable to Tilray Medical's multi-brand portfolio approach.
  • Canopy Growth Corporation: One of Canada's largest licensed cannabis producers, with a multi-brand portfolio (Tweed, Spectrum, DOJA) and DTC medical cannabis platform (Spectrum Therapeutics). Directly comparable as a multi-brand Canadian cannabis operator with both medical and consumer offerings.
  • Canna Farms (formerly owned by CanvasRx): Canadian medical cannabis producer offering dried flower, oils, and capsules directly to patients via online platform. Direct competitor to Tilray Medical as a Canadian LP focused on medical patients.
  • OrganiGram Holdings Inc. Canadian licensed cannabis producer with both medical and adult-use brands. Operates a patient registration platform similar to Tilray Medical for medical cannabis distribution across Canada.

Regional players

  • High Tide Inc. Canadian cannabis retail operator with Canna Cabana stores, plus ecommerce and accessories. Competes in Canadian cannabis retail though more focused on adult-use channels; provides a comparable Canadian-focused cannabis retail model.

Broad incumbents

  • Shoppers Drug Mart (Loblaw Companies): Canada's largest pharmacy retailer, which has licensed medical cannabis dispensaries in select provinces. Serves as a broader incumbent entering the medical cannabis space through traditional pharmacy infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Aphria social profiles

Digital presence

Aphria financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aphria leadership team

Management profile

Number of profiles

Aphria funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aphria M&A and investment

M&A and investment

M&A2 records

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aphria

What does Aphria do?

Aphria is a medical cannabis sub-brand sold through Tilray Medical's direct-to-consumer e-commerce platform (tilraymedical.ca) in Canada. The brand offers cannabis products including dried flower, oils, capsules, and edibles to registered patients who have submitted a medical document from a healthcare provider. Patients shop and order online with unit-priced products shipped directly across all Canadian provinces and territories.

Is Aphria a public or private company?

Aphria is a private company. It is classified as corporate owned and is currently operating.

When was Aphria founded?

Aphria was founded in 2014. It employs 251 to 500 people.

Where is Aphria based?

Aphria is headquartered in Leamington, Canada, in the North America region.

How does Aphria make money?

One revenue line is on record: medical Cannabis Product Sales.

Who are Aphria's main competitors?

Decibel Cannabis Company is listed as an emerging player. Direct peers are Aurora Cannabis Inc., Cronos Group Inc., Canopy Growth Corporation, Canna Farms (formerly owned by CanvasRx) and OrganiGram Holdings Inc.. High Tide Inc. is listed as a regional player. Shoppers Drug Mart (Loblaw Companies) is listed as a broad incumbent.

Does Aphria have an API?

No public API is recorded for Aphria.

What industry is Aphria in?

Aphria's product category is Medical Cannabis. Its primary akta.pro industry code is CRANAFAJ, Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.), with a secondary code of CRANAGAD, Cannabis Online Ordering for Delivery (Marketplace/Aggregator). Its NAICS code is 456 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ticker ReportAphria (TSE:APH) Stock Price Down 0.3% – Time to Sell?Aphria Inc. stock fell 0.3% on Wednesday, trading as low as C$24.06 and closing at C$24.23. Mid-day volume of 2,679 shares was an 86% drop from the average daily volume of 19,579. The company's market cap is C$278.45 billion with a P/E of 56.46.YahooIt's Been 5 Years Since Tilray Merged With Aphria to Create a "Global Cannabis Leader." Here's How It's Done Since ThenIn May 2021, Tilray Brands merged with Aphria in a major cannabis industry deal aimed at creating a global leader capable of expanding into new markets and achieving profitability. Five years later, despite becoming one of the world's leading cannabis companies, Tilray has struggled with choppy revenue growth and failed to achieve sustained profitability, with its stock declining more than 96%. The company has pursued diversification through beverage acquisitions (now roughly one-quarter of its business) amid limited growth prospects in the U.S. and Canadian markets, and analysts see no near-term catalyst for a turnaround.The Motley FoolIt's Been 5 Years Since Tilray Merged With Aphria to Create a "Global Cannabis Leader." Here's How It's Done Since ThenTilray Brands, formed by the 2021 merger with Aphria, has struggled with volatile revenue and persistent losses over five years. Its stock has fallen over 96% in that period, and beverages now account for about a quarter of its business. The company shows no near-term turnaround catalyst, making it a risky long-term investment.GlobeNewswireTilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth OpportunitiesTilray's Aphria RX GmbH received a trading license in Germany, allowing it to sell and distribute medical cannabis products to pharmacies, hospitals, and wholesalers. The license, combined with a cultivation license, expands Tilray's market position in Germany. The company aims to leverage the growing German market opportunity.GlobeNewswireEntourage Health Announces Amendment to Key Supply AgreementEntourage Health entered an amended supply agreement with HEXO Corp., extending the term and assigning obligations to Aphria Inc. under Tilray Brands. The agreement secures bulk cannabis biomass for Entourage's product portfolio, with fixed prices subject to limited adjustments.GlobeNewswireTilray Medical Launches Sleep-Oriented CBN Night Oil for Medical Cannabis Patients in CanadaTilray's Aphria launched CBN Night Oil, its first CBN oil for nighttime use, in Canada. The 50mL bottle contains 30mg CBN and 10mg THC per mL, formulated with broad-spectrum cannabis distillate. It is available on TilrayMedical.ca.PR NewswireCannabis Market Overview 2022: Key Developments, Global Trends and Forecasts to 2026ResearchAndMarkets.com published a market report showing combined global sales of CBD, medical and adult-use cannabis reached $37.4 billion in 2021, with forecasts projecting growth to $105 billion by 2026, driven by legalization rebounds and record-breaking sales following a difficult 2020. Major cannabis M&A activity highlighted in the report includes Jazz Pharmaceuticals' $7.2 billion acquisition of GW Pharmaceuticals in May 2021, the Aphria-Tilray merger, and Trulieve's $2.2 billion acquisition of Harvest Health and Recreation. The balance of cannabis production is shifting from traditional strongholds in Canada and the Netherlands toward warmer-climate regions including Latin America, the Mediterranean, and Africa, while Germany moves toward establishing what could become the largest cannabis industry outside North America.GlobeNewswireTilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and ProductsTilray Brands announced the launch of Tilray Medical, a global medical platform unifying its medical cannabis brands under one strategy. The portfolio includes Tilray, Aphria, Broken Coast, and Symbios, with products available in 20 countries. The company plans to expand its offering to patients worldwide.The Fresh ToastMeet The 10 Richest People In The Cannabis IndustryA report identifies the ten wealthiest individuals in the United States and Canadian cannabis industries, highlighting significant profits driven by market growth. The list features executives and investors such as Brendan Kennedy, former Tilray CEO whose net worth peaked at over $2 billion, and celebrities like Seth Rogen who have entered the sector. Other notable figures include Snoop Dogg, Bruce Linton, and company founders from major firms like MedMen and Aphria.GlobeNewswireLaunch of Tilray’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient CareTilray's Aphria launched medical cannabis oral strips in THC and CBD-rich varieties, using QuickStrip's proprietary technology for rapid absorption. The strips are available in three ratios and come in packs of 30 individually wrapped strips. The company expects to extend its leadership in the medical cannabis market.